Research Nester published a report titled “Drug
Delivery Devices Market: Global Demand Analysis & Opportunity
Outlook 2031” which delivers
detailed overview of the global drug delivery devices market in terms of market
segmentation by device type, route of administration, distribution channel, and
by region.
Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The global drug delivery devices market is anticipated
to attain a CAGR of ~5.5% over the forecast period, i.e., 2022 – 2031. On the
basis of route of administration, the market is segmented into oral,
transdermal, injectable, and others. Out of these, the injectable segment is
estimated to garner notable share over the forecast period, on account of the
ease and higher chance of successful implantation of injectable devices for
drug delivery.
Request
Report Sample@ https://www.researchnester.com/sample-request-3868
The global drug delivery devices market is estimated to
grow on the back of increasing demand for targeted drug delivery to treat
various diseases, including, cancer. Moreover, growing adoption of technology
in healthcare sector is estimated to fuel the growth of the market.
Furthermore, increase global health expenditure is bound to positively impact
the market growth. As per the
statistics by the World Bank, 9.856% of the global GDP was spent on healthcare,
in 2018. Along with this, the increasing cases of cancer mortality, combined
with rising prevalence of cancer are anticipated to propel the market growth.
The
research is global in nature and covers detailed analysis on the market in
North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden,
Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE,
Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and displayed
in the research report.
Get a sample copy of the report@ https://www.researchnester.com/reports/drug-delivery-devices-market/3868
Increasing
Cancer Prevalence to Boost the Market Growth
According to the data by the World Health
Organization (WHO), nearly 10 million deaths were caused by cancer in 2020.
Targeted drug therapy is one of the most
common treatment approaches to target cancerous growth. The increasing
implementation of targeted drug delivery for cancer treatment is estimated to
boost the market growth. Moreover, the escalating incidences of cancer
globally, is further expected to boost the market growth.
However, risks of needle stick injuries are
expected to operate as key restraint to the growth of global drug delivery
devices market over the forecast period.
This report also provides the existing
competitive scenario of some of the key players of the global drug delivery
devices market which includes company profiling of Mylan N.V., Antares Pharma,
Inc., Novartis
International AG, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka
Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited, Teva
Pharmaceutical Industries Ltd. The
profiling enfolds key information of the companies which encompasses business
overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the global
drug delivery devices market that will help industry consultants, equipment
manufacturers, existing players searching for expansion opportunities, new
players searching possibilities and other stakeholders to align their market
centric strategies according to the ongoing and expected trends in
the future.
Request Report Sample@ https://www.researchnester.com/sample-request-3868
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
No comments:
Post a Comment